m+Medelevator.RU
← Поиск публикаций
Frontiers in veterinary science · 2026

Case Report: Palliative benefit of hypofractionated radiation therapy (6 Gy × 6 fractions) with temporary tracheostomy in a cat with laryngeal B-cell lymphoma progressing during chemotherapy.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kim Jingyu, Kim Jaewon, Jeong Inseong, Choi Hoon, Kim Younghwan, Lee Suhyung, Eom Kidong, Kim Jaehwan

Аннотация

A 12-year-old spayed female Maine Coon cat was diagnosed with cervical T-cell-rich B-cell lymphoma. During modified L-CHOP-based chemotherapy, the cat developed progressive upper airway obstruction associated with a laryngeal lesion. Initial CT suggested contiguous laryngeal involvement, and follow-up imaging revealed severe laryngeal narrowing. An emergency temporary tracheostomy was performed for airway stabilization, and subsequent punch biopsy of the laryngeal lesion was most consistent with diffuse large B-cell lymphoma. Hypofractionated palliative radiation therapy (6 Gy × 6 fractions; total dose 36 Gy) was initiated to address the obstructive mass. Progressive tumor shrinkage was observed during treatment, and by the fourth fraction the tracheostomy tube was successfully removed without recurrence of airway obstruction. Follow-up CT 17 days after radiation therapy initiation showed no visible laryngeal lesion, and no respiratory signs or airway obstruction recurred before the cat died on day 27 following clinically suspected systemic disease progression. This case suggests that hypofractionated radiation therapy, in combination with temporary tracheostomy, may provide rapid and effective relief of tumor-induced upper airway obstruction in cats with laryngeal B-cell lymphoma progressing during chemotherapy.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты